| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/24/2013 | CN103211760A Clevidipine butyrate intralipid and preparation method thereof |
| 07/24/2013 | CN103211759A Puerarin nanocrystalline medical composition and preparation method thereof |
| 07/24/2013 | CN103211758A Liquid crystal nanoparticle transdermal agent and preparation method thereof |
| 07/24/2013 | CN103211757A Edaravone injection and preparation method thereof |
| 07/24/2013 | CN103211756A Long-acting doxycycline hydrochloride injection for animals and preparation method thereof |
| 07/24/2013 | CN103211755A Production method of sterile stable azithromycin eye drops |
| 07/24/2013 | CN103211754A Production method of sterile stable pirenoxine sodium eye drops |
| 07/24/2013 | CN103211752A Preparation and application of in-situ gel used for nystatin pH sensitive type vagina |
| 07/24/2013 | CN103211751A Medical composition containing vilazodone and preparation method thereof |
| 07/24/2013 | CN103211750A Method of preparing soy isoflavone nanoparticles by precipitation with compressed antisolvent (PCA) using a supercritical fluid |
| 07/24/2013 | CN103211732A Preparation method and application of mixture with tyrosinase inhibitory activity |
| 07/24/2013 | CN102836167B Compound gentamycin procaine gastric floating sustained-release pellets |
| 07/24/2013 | CN102772385B Stable tretinoin tablets and preparation method thereof |
| 07/24/2013 | CN102755366B Honeysuckle soft capsule containing chlorogenic acid compound |
| 07/24/2013 | CN102755342B Compound paracetamol injection and preparation method thereof |
| 07/24/2013 | CN102743378B Composition containing 18 amino acids |
| 07/24/2013 | CN102727521B Preparation method of gentamycin bismuth carbonate capsule content intestinal release pellets |
| 07/24/2013 | CN102727483B Pharmaceutical composition containing curzerene and borneol |
| 07/24/2013 | CN102698274B Medicine composition for treating intractable escherichia coli of fowls |
| 07/24/2013 | CN102627631B Benzoheterocycle compound and preparation method as well as medical application thereof |
| 07/24/2013 | CN102626417B Use of arctiin in preparation of drug or health food |
| 07/24/2013 | CN102617435B Leucosceptrum canum chinone, preparation method and application |
| 07/24/2013 | CN102614459B Traditional Chinese medicine spray for rapidly curing myocardial ischemia and preparation method thereof |
| 07/24/2013 | CN102614196B Application of phenylacetyl fluorobenzene salicylamide compound in preparation of anti-breast-cancer medicines |
| 07/24/2013 | CN102600071B Method for preparing sinomenine hydrochloride infusion solutions and freeze-dried powder injections |
| 07/24/2013 | CN102580093B Injection for preventing piglet diseases and preparation method thereof |
| 07/24/2013 | CN102579450B Application of 5-fluorouracil in preparing circumscribed chronic eczema therapeutic drug |
| 07/24/2013 | CN102552125B Injection composition containing oxiracetam and preparation method and application thereof |
| 07/24/2013 | CN102552122B Method for preparing sinomenine hydrochloride injection |
| 07/24/2013 | CN102531966B Novel crystal form D of Retigabine and preparation method thereof |
| 07/24/2013 | CN102526667B Loquat leaf/ginger composition for reducing vomiting due to cancer chemotherapy and enhancing effect of cancer chemotherapy, and preparation method thereof |
| 07/24/2013 | CN102526012B Application of retinoic acid and derivatives thereof in preparation of medicines for treating hepatic fibrosis |
| 07/24/2013 | CN102499924B Application of porphyrin modified by diethylene triamine pentaacetic acid or ethylene diamine tetraacetic acid or ethylene diamine tetraacetic acid |
| 07/24/2013 | CN102488655B N3-ortho toluene formoxyl uracil nanosuspension and lyophilized preparation thereof |
| 07/24/2013 | CN102471770B Antigen peptide and use thereof |
| 07/24/2013 | CN102430064B Composition for tonifying primordial qi and removing meridian obstruction and regulating blood and preparation method thereof |
| 07/24/2013 | CN102423457B Traditional Chinese medicine capsules for treating coronary heart disease |
| 07/24/2013 | CN102416181B Biodegradable high-polymer bonded photoactive Pt (IV) anticancer medicament micelle and preparation method thereof |
| 07/24/2013 | CN102389408B Application of saturated amine compound in preparing medicament for treating ischemic diseases |
| 07/24/2013 | CN102373213B Mycobacterium tuberculosis surface lipolysaccharide-antistatic nucleic acid aptamer and application thereof |
| 07/24/2013 | CN102358749B Roxithromycin ambroxol tablet composite and preparing method thereof |
| 07/24/2013 | CN102343025B Aloe preparation and preparation method thereof |
| 07/24/2013 | CN102336740B Novel imidazole compound and its application |
| 07/24/2013 | CN102327368B Chinese lizardtail rhizome or herb rootstock total effective fraction and preparation method and application thereof |
| 07/24/2013 | CN102321204B Selenium resin load, and intermediate, preparation method and application thereof |
| 07/24/2013 | CN102260277B Novel benzoxazine oxazolidinone compound as well as preparation method thereof and purpose thereof |
| 07/24/2013 | CN102256942B New polymorphic form of 1- (4- { l- [ (e) -4-cyclohexyl--3-trifluoromethyl-benzyloxyimino] -ethyl) -2-ethyl-benzyl) -azetidine-3-formic acid |
| 07/24/2013 | CN102249987B Combretastatin compound and preparation method and application thereof |
| 07/24/2013 | CN102228457B Pharmaceutical composition for treating diabetes and complication thereof |
| 07/24/2013 | CN102219759B Aryl methanamide compounds and preparation method, medicinal compositions and application thereof |
| 07/24/2013 | CN102219751B Pentadienone-containing 4-substituted quinazoline derivative, preparation method and use thereof |
| 07/24/2013 | CN102210808B Method for preparing Chinese medicinal composition for treating infantile pharyngitis |
| 07/24/2013 | CN102204882B Pharmaceutical composition containing ibuprofen |
| 07/24/2013 | CN102188461B Application of screwtree root extractive in the preparation of anti-HBV medicament |
| 07/24/2013 | CN102188370B Resveratrol injection solution and intravenous injection |
| 07/24/2013 | CN102153564B Nitrogen-atom-containing arteannuin dimers, and preparation method and application thereof |
| 07/24/2013 | CN102151278B Use of 2-deoxy-D-glucose in prevention and treatment of viral diseases in livestock |
| 07/24/2013 | CN102137652B Use of an N-acyl amino acid selected from among N-palmitoyl alanine, N-palmitoyl glycine, N-palmitoyl isoleucine, and N-cocoyl alanine as an active agent controlling the proportion of basal keratinocytes of the human skin epidermis and expressing the nuclear form of surviving, and anti-aging cosmetic composition comprising same |
| 07/24/2013 | CN102133217B Applications of pyridazinones compound taking N as bridged bond in preparation of medicine for resisting tumor |
| 07/24/2013 | CN102131506B Polymorphic form of granisetron hydrochloride and methods of making the same |
| 07/24/2013 | CN102120036B Nano micelle of biodegradable macromolecular-bonding Pt(IV) anti-cancer medicament and preparation method thereof |
| 07/24/2013 | CN102093341B Indole ring substituted pyrazole carboxylic acid endothelin receptor antagonist as well as preparation method and application thereof |
| 07/24/2013 | CN102083441B Use of nifurtimox for treating giardiasis |
| 07/24/2013 | CN102058560B Dihydromyricetin soft capsules and preparation method thereof |
| 07/24/2013 | CN102026631B Emollient composition for the preventive treatment of atopic dermatitis |
| 07/24/2013 | CN102020546B PTP1B inhibitor and preparation and application in preparing drug for treating type 2 diabetes mellitus thereof |
| 07/24/2013 | CN101925351B Cytostatic composition |
| 07/24/2013 | CN101910125B Compounds from mycelium of antrodia cinnamomea and use thereof |
| 07/24/2013 | CN101885722B Heterocycle alkyne and benzene compound, medicinal composition and application thereof |
| 07/24/2013 | CN101862333B Stable sodium levofolinate oral preparation and preparation method thereof |
| 07/24/2013 | CN101861314B 1-hydroxyl-2- naphthoate of N4-[(2, 2-difluoro-4N-benz0 [1,4] 0xazin-3-one) -6-yl] -5-fluoro-N2- [3- (methylaminocar bonylmethyleneoxy) phenyl] 2, 4-pyrimidinediamine |
| 07/24/2013 | CN101848712B Treatment of progressive neurodegenerative disease with ibudilast |
| 07/24/2013 | CN101827595B Substituted piperazines and piperidines as modulators of the neuropeptide Y2 receptor |
| 07/24/2013 | CN101827593B Isothiazolopyridinones useful for the treatment of (inter alia) cystic fibrosis |
| 07/24/2013 | CN101817787B Androgen receptor antagonist for resisting prostate cancer |
| 07/24/2013 | CN101808637B Pharmaceutical composition |
| 07/24/2013 | CN101778847B Crystalline pyridazine compound |
| 07/24/2013 | CN101730684B Sulfonyl-quinoline derivatives |
| 07/24/2013 | CN101723930B Shikimic acid compound and preparation method and application thereof |
| 07/24/2013 | CN101691367B Piperazine and <2,1-a> isoquinoline compounds with antifungal activity and salts thereof |
| 07/24/2013 | CN101688227B Macrolactams prepared by engineered biosynthesis |
| 07/24/2013 | CN101687902B 8-beta-substituted estratrienes as selectively active estrogens |
| 07/24/2013 | CN101669917B Scopolamine hydrobromide orally disintegrating microencapsule tablets based on NIMS system |
| 07/24/2013 | CN101668760B Aminopyrimidines useful as inhibitors of protein kinases |
| 07/24/2013 | CN101663302B Nitrogenated fused ring derivative, pharmaceutical composition comprising the same, and use of the same for medical purposes |
| 07/24/2013 | CN101652147B Combined use of dipeptidyl peptidase IV inhibitor compound and sweetener |
| 07/24/2013 | CN101613386B Gambogic acid cyclized analog, preparation method and application thereof |
| 07/24/2013 | CN101573106B Soft capsules comprising palonosetron hydrochloride having improved stability and bioavailability |
| 07/24/2013 | CN101506157B Co-crystals of pyrrolidinones |
| 07/24/2013 | CN101503373B 2-amino-1-(4-nitro phenyl)-1-ethanol metalloid protease inhibitor, and preparation and use thereof |
| 07/24/2013 | CN101405264B Piperidinyl urea derivatives as inhibitors of soluble epoxide hydrolase for the treatment of hypertension, inflammations and other diseases |
| 07/24/2013 | CN101402613B Substituted phenoxy oxygen alkylamine triazole alcohol antimycotic compounds and method of preparing the same |
| 07/24/2013 | CN101378666B Carbohydrate composition for flat glucose response |
| 07/24/2013 | CN101370519B Combination of angiopoietin-2 antagonist and of VEGF-A, KDR and/or Flt1 antagonist for treating cancer |
| 07/24/2013 | CN101365461B Derivatives of sulindac, use thereof and preparation thereof |
| 07/24/2013 | CN101362773B Heterocyclic boronic acid compounds |
| 07/24/2013 | CN101326171B Novel dual peptidase inhibitors as prodrugs for the therapy of inflammatory and other disorders |
| 07/24/2013 | CN101309679B 胶冻组合物 Jelly composition |
| 07/24/2013 | CN101296898B Histamine-3 receptor antagonists |
| 07/24/2013 | CN101258131B 6-arylalkylamino- 2,3,4,5-tetrahydro-1h-benzo[d]azepines as 5-ht2c receptor agonists |